For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Once enabled, click here to view the site.

singup link button why should I sign up?
Login as Volunteer Login as Study team member
OR

Studies you may be eligible for. 13

Based on the information you provided, we found the following studies.

  • Randomized Double-Blind Ph 3 Study of Ruxolitinib or Placebo in Combination With Capecitabine in Subjects With Advanced/Metastatic Pancreatic Cancer Who Failed/Are Intolerant to 1st-Line Chemotherapy Study purpose: find out if investigational drug ruxolitinib is effective and safe in combination with chemotherapy medicine capecitabine; determine how long subjects with pancreatic cancer live after receiving treatment with capecitabine and ruxolitinib against those who receive capecitabine alone. This study is researching all of the following topics: Pancreatic cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Improving Adherence to Oral Cancer Agents and Self-Care of Symptoms Using an IVR The purpose of the study is to: (1) determine if daily reminders will help patients take their anti-cancer pills as prescribed and; (2) test strategies to manage symptoms between doctor office visits. We are hoping to learn better ways to support patients who are prescribed oral anti-cancer pills. This study is researching all of the following topics: Breast cancer Colon Cancer ( Malignant tumor of colon ) Melanoma Pancreatic cancer Prostate cancer Sarcoma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 21 years old
  • Phase 2 Study of Gemcitabine, Cisplatin +/- Veliparib in Patients With Pancreas Adenocarcinoma with BRCA/ PALB2 Mutation and a Phase 2 Study of Veliparib in Previously Treated Pancreas Adenocarcinoma Part 1: To evaluate a combination of gemcitabine and cisplatin with or without veliparib in subjects pancreatic cancer. Veliparib is a new drug that belongs to a class of drugs called PARP inhibitors. Part 2: To evaluate veliparib in subjects with previously treated advanced pancreatic cancer. This study is researching all of the following topics: Pancreatic cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A research study treating patients who have a diagnosis of pancreatic cancer, that has been staged as borderline operable, with chemotherapy and radiation therapy prior to surgery. To examine the order and results of treatments including chemotherapy and radiation therapy and surgery for pancreatic tumors that are staged as borderline operable. This study is researching all of the following topics: Colon Cancer ( Malignant tumor of colon ) Pancreatic cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A phase 3, multicenter, open-label, randomized study of nab-paclitaxel plus gemcitabine versus gemcitabine alone in subjects with surgically resected pancreatic adenocarcinoma. The purpose of this study is to determine whether the addition of the investigational drug nab-paclitaxel to gemcitabine will help to delay pancreatic cancer from coming back after surgery. Gemcitabine is a drug commonly used after pancreatic resection. This study is researching all of the following topics: Pancreatic cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI4736 in Subjects with Advanced Solid Tumors The purpose of this phase 1 research study is to evaluate the safety of an investigational drug, MEDI4736, a drug believed to boost a type of immune cell to assist in identifying and attacking cancer cells to determine the dose and schedule that is safe and tolerable in subjects with solid tumors. This study is researching all of the following topics: Breast cancer Colon Cancer ( Malignant tumor of colon ) Esophagus cancer HCC, Liver cancer Kidney Cancer ( Malignant tumor of kidney ) Laryngeal cancer, Cancer of the larynx, Voice box cancer Lung cancer NPC, Nasal cancer Oral / Mouth cancer Pancreatic cancer Salivary Gland Cancer Skin Cancer ( Malignant neoplasm of skin ) This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Phase I/II Dose Escalation Study to Determine the Safety, Pharmacokinetics and Pharmacodynamics of Intravenous TKM-080301 in Patients with Advanced Solid Tumors Study purpose: test safety of TKM-080301 and see what effect (good and bad) it has on you and your cancer;find highest dose of TKM-080301 that can be given without causing bad side effects;find dose of TKM-080301 that should be used in future studies;evaluate how TKM-080301 is absorbed by your body. This study is researching all of the following topics: Ovarian cancer Pancreatic cancer Thyroid cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Phase I safety study of intratumoral injection of Clostridium novyi-NT spores in patients with treatment-refractory solid tumor malignancies This study is being done to learn whether treatment with Clostridium novyi-NT spores (NT refers to non-toxin producing) is safe and effective in patients with advanced cancers that can no longer be controlled with standard therapy or cancers for which there is no standard effective treatment. This study is researching all of the following topics: Adrenal cancer BCC, Basal cell skin cancer Bladder cancer Bone cancer Breast cancer Cervical cancer Colon Cancer ( Malignant tumor of colon ) Esophagus cancer Fallopian tube cancer HCC, Liver cancer Kidney Cancer ( Malignant tumor of kidney ) Laryngeal cancer, Cancer of the larynx, Voice box cancer Lung cancer Lymphoma NPC, Nasal cancer Oral / Mouth cancer Ovarian cancer Pancreatic cancer Prostate cancer Salivary Gland Cancer Sarcoma Squamous cell skin cancer Thyroid cancer Uterine / Uterus cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Dose Escalation Trial of the Wee1 Inhibitor MK1775, in Combination with Gemcitabine (+Radiation) for Patients with Unresectable Adenocarcinoma of the Pancreas We are adding an experimental agent (drug) to the standard treatment for pancreatic cancer (radiation and gemcitabine {chemo drug}). This is for pancreatic cancer that cannot be treated with surgery. The experimental agent (MK-1775) has not been used for pancreatic cancer before this. This study is researching all of the following topics: Pancreatic cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • All ages welcome
  • A Phase I/II Study of the Combination of Temozolomide and Pazopanib in Advanced Pancreatic Neuroendocrine Tumors (PNET) Goals:See if combination of temozolomide and pazopanib is safe and effective in improving outcomes.Part 1 will try to find out what effects this drug combination has on you and your cancer, and find a dose to use in Part 2 of the trial.Part 2 will study effects of the drugs on a larger group. This study is researching all of the following topics: Pancreatic cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
Showing 1-10 of 13 studies
Show more studies